UCFA
ATRS

United Capital Financial Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

United Capital Financial Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-29,124
Closed -$50K – 1310
2015
Q3 		$50K Buy
+29,124
New +$57.1K ﹤0.01% 1224

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

United Capital Financial Advisors's ATRS Position: Q4 2015 in Review

United Capital Financial Advisors sold out of Antares Pharma, Inc. (ATRS) in Q4 2015, closing a stake of 29,124 shares — an estimated $50K sold.

United Capital Financial Advisors first reported a position in ATRS in Q3 2015 and held it in 1 quarter. The position peaked at $50K in Q3 2015. 88 funds tracked by Wall St. Rank hold ATRS as of Q4 2015.

  • United Capital Financial Advisors reported no remaining Antares Pharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • United Capital Financial Advisors sold 29,124 Antares Pharma, Inc. shares in Q4 2015, an estimated $50K.
  • United Capital Financial Advisors first reported a position in Antares Pharma, Inc. in Q3 2015 and held it in 1 quarter.
  • United Capital Financial Advisors's Antares Pharma, Inc. position peaked at $50K in Q3 2015.
  • 88 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2015.

Based on United Capital Financial Advisors's 13F filing for Q4 2015, filed 11 Feb 2016.